Promise and potential pitfalls of anti-VEGF drugs in retinopathy of prematurity | British Journal of Ophthalmology

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via AAO

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via AAO

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Citation Tools

Mailbox

PostScript

Promise and potential pitfalls of anti-VEGF drugs in retinopathy of prematurity

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Darlow BA, Gilbert C, Quinn GE, et al

Promise and potential pitfalls of anti-VEGF drugs in retinopathy of prematurity

British Journal of Ophthalmology 2009;93:986.